BMRN, GENZ Phase III Aldurazyme data

BioMarin (BMRN; SWX:BMRN) and partner Genzyme (GENZ) reported six-month extension data from a previously reported Phase III trial in 45 patients with

Read the full 223 word article

How to gain access

Continue reading with a
two-week free trial.